Genpharmasec Ltd

NSE: ADIRASA · BSE: 531592 · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹1.10
Market cap: ₹60.91 Cr
Revenue (annual): ₹139.9 Cr
Net profit (annual): ₹1.60 Cr
P/E (TTM): -500.0×Sector 47.4×
Promoter holding: 29.98%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Buying 3 Financial Results 3 Board Meeting Date 3 Other Announcement 2 New Order Win 1 Management Change 1 Fund Raise 1 Debt & Borrowing 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

14 Apr 2026 15:45 IST BSE

Debt & Borrowing

Genpharmasec Debt & Borrowing

Genpharmasec Ltd (BSE: 531592) declared it does not qualify as a Large Corporate for FY 2026-27 under SEBI debt framework. The company reported zero outstanding borrowings as of March 31, 2026. Consequently, it is not required to fulfill mandatory debt market borrowing requirements.

Read the filing ↗